99Tcm-tetrofosmin在乳腺癌及其转移灶显像中的应用

章斌

downloadPDF
文章导航 > 国际放射医学核医学杂志  > 2001,  25 > 1: (12-15)  
引用本文:
shu
Citation:
shu

99Tcm-tetrofosmin在乳腺癌及其转移灶显像中的应用

  • 215006 江苏苏州, 苏州大学附属第一医院核医学科

    • 作者简介: 章斌(1972-),男,江苏苏州人,苏州大学附属第一医院核医学科硕士研究生,主要从事肿瘤核医学研究。;

  • 中图分类号: R817.4

Application of 99Tcm-tetrofosmin scintigraphy in the diagnosis of breast cancer and metastases

  • Department of Nuclear Medicine, First Affiliated Hospital of Suzhou University, Suzhou Jiangsu 215006, China

  • CLC number: R817.4

  • 摘要: 99Tcm-tetrofosm in作为亲肿瘤显像剂,对乳腺癌原发病灶和腋窝淋巴结转移的诊断有良好的灵敏度、特异性和准确率,可应用于乳腺癌全身骨转移和术后复发的诊断,其应用于乳腺癌前哨淋巴结转移的诊断、作为P-糖蛋白功能显像剂和三维立体定位引导孔针型活检等领域有着良好的发展前景。99Tcm-tetrofosm in乳腺癌及转移灶显像可与其他乳腺癌检查方法相结合提高乳腺癌诊断的准确率。
    Abstract: 99Tcm-tetrofosmin as a positive indicator in oncology,99Tcm-tetrofosmin scintigraphy has high sensitivity,specificity and accuracy in diagnosis of primary breast cancer, of local recurrence and of axillary lymph node metastases.99Tcm-tetrofosmin can also be used to detect bone metastases and recurrence after surgery. Furthermore,99Tcm-tetrofosmin presents promising perspectives in sentinel lymph node detection and imaging, in function imag-ing of P-glycoprotein and in guiding a biopsy. Associated with other methods,99Tcm-tetrofosmin scintigraphy improves the accuracy of detecting breast cancer.
  • [1] Rambaldi PF,Mansi L,Procaini E,et al.Breast can-cer detestion with 99Tcm-tetrofosmin[J].Clin Nucl Med,1995,20:703-705.
    [2] Mansi L,Rambaldi PF,Cuccurullo V,et al.Diagnos-tic and prognostic role of 99Tcm-tetrofosmin in breast cancer[J].Q J Nucl Med,1997,41:239-250.
    [3] Arbab AS,Koizumi K,Toyama K,et al.Uptake of technetium-99m-tetrofosmin,technetium-99m-MIBI and thallium-201 in tumor cell lines[J].J Nucl Med,1996,37:1551-1556.
    [4] De Jong M,Bernard BF,Breeman WAP,et al.Com-parison of uptake of 99Tcm-MIBI,99Tcm-tetrofosmin and 99Tcm-Q12 into human breast cancer cell lines[J].Eur JNucl M ed,1996,23:1361-1366.
    [5] Ballinger JR,Bannerman J,Boxen I,et al.Tech-netium-99m-tetrofosmin as a substrate for P-glycopro-tein:in vitro studies in multidrugresistant breast tu-mor cells[J].J Nucl Med,1996,37:1578-1582.
    [6] Higley B,Smith FW,Smith T,et al.Technetium-99m-1,2-bis[bis (2-ethoxyethyl) phosphino] ethane:hu-man biodistribution,dosimetry and safety of a new myocardial perfusion imaging agent[J].J Nucl Med,1993,34:30-38.
    [7] Mansi L,Rambaldi PF,Procaccini E,et al.Scinti-mammography with technetium-99m-tetrofosmin in the diagnosis of breast cancer and lymph node metas-tases[J].Eur J Nucl Med,1996,23:932-939.
    [8] Batista JF,Solano ME,Oliva JP,et al.Usefulness of 99Tcm-tetrofosmin scintimammography in palpable breast tumours[J].Nucl Med Commun,1997,18:338-340.
    [9] Buscombe JR,Cwikla JB,Thakrar DS,et al.Prone SPET scintimammography[J].Nucl Med Commun,1999,20:237-245.
    [10] Adalet I,Demirkol MO,Muslumanoglu M,et al.99Tcm-tetrofosmin scintigraphy in the evaluation of pal-pable breast masses[J].Nucl Med Commun,1997,18:118-121.
    [11] Akcay MN,Akin Y,Karabag B,et al.99Tcm-tetrofos-min in breast carcinoma and axillary Iymph node metastases:a comparative study with 99Tcm-MIBI[J].Clin Nucl Med,1997,22:832-834.
    [12] Takayame T,Kinuya S,Sugiyama M,et al.99Tcm-tetrofosmin scintimammography in palpable breast tu-mours[J].Ann Nucl Med,1998,12:293-296.
    [13] Lacic M,Bokulic T,Lukac J,et al.Bone marrow im-munoscintigraphy for the detection of skeletal metas-tases in patients with breast cancer[J].Nucl Med Commun,1999,20:135-143.
    [14] Keshtgar M RS,Ell PJ.Sentinel lymph node detection and imaging[J].Eur J Nucl Med,1999,26:57-67.
    [15] Kabasakal L,Halac M,Nisli C,et al.The effect of P-glycoprotein function inhibition with cyclosporine A on the biodistribution of Tc-99m sestamibi[J].Clin Nucl Med,2000,25:20-23.
    [16] Yutani K,Tatsumi M,Shiba E,et al.Comparison of dual-head coincidence gamma camera FDG PET in de-tection of breast cancer and axillary lymph node metas-tasis[J].JNucl Med,1999,40:1003-1008.
    [17] Rostom AY,Powe J,Kandil A,et al.Positron emis-sion tomography in breast cancer:a clinico-pathologi-cal correlation of results[J].Br J Radiol,1999,72:1064-1068.
    [18] Bleckmann C,Dose J,Bohuslavizki KH,et al.Effect of attenuation correction on lesion detectability in FDG PET of breast cancer[J].JNucl Med,1999,40:2021-2024.
    [19] Amano S,Inoue T,Tomiyoshi K,et al.In vivo com-parison of PET and SPECT radiopharmaceuticals in detecting breast cancer[J].J Nucl Med,1998,39:1424-1427.
    [20] Dehdashti F,Flanagan FL,Mortimer JE,et al.Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy[J].Eur J Nucl Med,1999,26:51-56.
    [21] Fischer U,Kopka L,Grabbe E.Breast carcinoma:ef-fect of preoperative constrast-enhanced MR imaging on the therapeutic approach[J].Radiology,1999,213:881-888.
    [22] Chen DR,Chang PF,Huang YL.Computer-aided di-agnosis applied to U S of solid breast nodules by using neural networks[J].Radiology,1999,213:407-412.
    [23] Zonderland HM,Coerkamp E,Hermans J,et al.Di-agnosis of breast cancer of contribution of US as an ad-junct to mammography[J].Radiology,1999,213:413-422.
  • [1] 何建华 . 99Tcm-MIBI用于乳腺癌诊断的评价. 国际放射医学核医学杂志, 2002, 26(2): 64-67.
    [2] 张高潮 , 马丽 , 寇莹 , 陈正福 , 宋晏 , 徐金亮 . 99Tcm-tetrofosmin SPECT诊断肺部肿瘤的临床价值. 国际放射医学核医学杂志, 2015, 39(4): 303-307. doi: 10.3760/cma.j.issn.1673-4114.2015.04.007
    [3] 贾志云 , 邓候富 . 99Tcm-甲氧基异丁基异腈显像在白血病中的应用价值. 国际放射医学核医学杂志, 2005, 29(6): 252-254.
    [4] 张一秋 , 石洪成 . 99Tcm-甲氧基异丁基异腈SPECT预测肺癌多药耐药及化疗疗效. 国际放射医学核医学杂志, 2008, 32(6): 329-332.
    [5] 川玲 , 赵文锐 . 99Tcm-MIBI在检测乳腺癌中的作用. 国际放射医学核医学杂志, 2000, 24(4): 155-157.
    [6] 程兵 . 99Tcm-MIBI显像检测乳腺癌多药耐药. 国际放射医学核医学杂志, 2002, 26(2): 67-71.
    [7] 黄建敏 , 曲雁 , 潘莉萍 . 恶性骨肿瘤多药耐药的99Tcm-MIBI体层显像研究. 国际放射医学核医学杂志, 2005, 29(4): 169-170.
    [8] 叶慧 , 莫逸 , 谢爱民 , 彭翔 . 18F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究. 国际放射医学核医学杂志, 2008, 32(3): 147-150.
    [9] 陆汉魁 , 林祥通 , 刘家慧 , 林汉 . 乳腺癌和前列腺癌的类固醇受体显像研究现状. 国际放射医学核医学杂志, 1996, 20(3): 106-109.
    [10] 陈璟 , 吴华 . 乳腺癌前哨淋巴结探查的研究进展. 国际放射医学核医学杂志, 2002, 26(5): 222-224.
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  1010
  • HTML全文浏览量:  83
  • PDF下载量:  3
出版历程
  • 收稿日期:  2000-06-13

99Tcm-tetrofosmin在乳腺癌及其转移灶显像中的应用

    作者简介:章斌(1972-),男,江苏苏州人,苏州大学附属第一医院核医学科硕士研究生,主要从事肿瘤核医学研究。
  • 215006 江苏苏州, 苏州大学附属第一医院核医学科
  • 收稿日期: 2000-06-13

摘要: 99Tcm-tetrofosm in作为亲肿瘤显像剂,对乳腺癌原发病灶和腋窝淋巴结转移的诊断有良好的灵敏度、特异性和准确率,可应用于乳腺癌全身骨转移和术后复发的诊断,其应用于乳腺癌前哨淋巴结转移的诊断、作为P-糖蛋白功能显像剂和三维立体定位引导孔针型活检等领域有着良好的发展前景。99Tcm-tetrofosm in乳腺癌及转移灶显像可与其他乳腺癌检查方法相结合提高乳腺癌诊断的准确率。

English Abstract

    全文HTML

参考文献 (23)

目录

    /

    返回文章
    返回

    版权所有©中华医学会   备案号：津ICP备15006720号-3

    地址：天津市南开区白堤路238号电话：86-22-58089989
    86-22-85682389    传真：022-87890607

    本系统由 北京仁和汇智信息技术有限公司 开发 技术支持： info@rhhz.net